T1	Participants 72 122	patients with malignant pleural mesothelioma (MS01
T2	Participants 169 199	Malignant pleural mesothelioma
T3	Participants 517 613	409 patients with malignant pleural mesothelioma, from 76 centres in the UK and two in Australia
